Digestive oncology department, European hospital Georges-Pompidou, AH-PH, Paris, France.
Clin Res Hepatol Gastroenterol. 2013 Feb;37(1):e29-31. doi: 10.1016/j.clinre.2012.05.008. Epub 2012 Jul 4.
Hepatocellular carcinoma (HCC) is the first malignant hepatic tumor in frequency, with an incidence of 10 new cases per 100,000 people a year, in France. HCC metastasis disseminate hematogenously. The most frequent metastatic sites are lungs, bones, and liver.
We detail the approach to diagnosis and the treatment of a patient with an unusual late recurrence of HCC, which was discovered fortuitously. The metastasis was located in the subcutaneous tissue of the right gluteal fold.
This case poses a problem of detection in the clinical practice. Indeed, the recurrence occurred 9 years after the HCC. Molecular analysis of our case could make us progress in our knowledge of this disease, and to associate it to a patient's group with similar HCC evolutive profile.
肝细胞癌（HCC）是法国最常见的第一大肝脏恶性肿瘤，每年每 10 万人中有 10 例新发病例。HCC 转移通过血行播散。最常见的转移部位是肺、骨和肝脏。
我们详细介绍了一位 HCC 罕见晚期复发患者的诊断和治疗方法，该患者是偶然发现的。转移位于右侧臀褶的皮下组织中。
该病例在临床实践中提出了一个检测问题。事实上，HCC 复发发生在 9 年后。对我们病例的分子分析可以使我们对该疾病有更多的了解，并将其与具有相似 HCC 进化特征的患者群体联系起来。
